ストックスクリーナーアプリを入手
2.90
3.97%
-0.12
アフターアワーズ：
2.95
0.05
+1.72%
Aquestive Therapeutics Inc (AQST) 最新ニュース
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of “Buy” from Analysts - Defense World
Aquestive stock falls amid Libervant approval, Anaphylm update - MSN
Bank of New York Mellon Corp Reduces Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World
Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy - Seeking Alpha
Aquestive Therapeutics: Not For Me, But Attractive (NASDAQ:AQST) - Seeking Alpha
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) P/S Is On The Mark - simplywall.st
What is HC Wainwright’s Estimate for AQST Q1 Earnings? - Defense World
What is HC Wainwright’s Forecast for AQST FY2026 Earnings? - Defense World
Aquestive Therapeutics (NASDAQ:AQST) Given Buy Rating at HC Wainwright - Defense World
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks
Aquestive Therapeutics Advances Product Pipeline and Market Access - TipRanks
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript - Insider Monkey
Buy Rating on Aquestive Therapeutics Driven by Anaphylm’s Regulatory Progress and Strategic Launch Preparations - TipRanks
Aquestive Therapeutics Stock Dips After-Hours On Q4 Miss — Retail Eyes Silver Linings - MSN
Lake Street Capital Lowers Aquestive Therapeutics (NASDAQ:AQST) Price Target to $8.00 - Defense World
Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
Aquestive Therapeutics price target lowered to $4.75 from $5.50 at Alliance Global Partners - TipRanks
New York State Common Retirement Fund Grows Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World
Aquestive Therapeutics Reports 2024 Financial Results and Strategic Progress - TipRanks
Aquestive Therapeutics: Strategic Advancements and Financial Strength Underpin Buy Rating - TipRanks
Earnings call transcript: Aquestive Therapeutics Q4 2024 misses estimates By Investing.com - Investing.com UK
Earnings call transcript: Aquestive Therapeutics Q4 2024 misses estimates - Investing.com
Aquestive Therapeutics: Q4 Earnings Snapshot - Midland Daily News
Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates - MSN
Aquestive Therapeutics Q4 Net Loss Widens, Revenue Falls; 2025 Revenue Outlook Issued - Marketscreener.com
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Aquestive Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Nasdaq
Aquestive Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aquestive Therapeutics reports Q4 EPS (19c), consensus (13c) - TipRanks
Aquestive Therapeutics misses Q4 estimates, shares fall By Investing.com - Investing.com South Africa
Aquestive Therapeutics misses Q4 estimates, shares fall - Investing.com India
Aquestive Therapeutics Initiates Anaphylm NDA Filing Process - TipRanks
Aquestive Therapeutics sees FY25 revenue $47M-$56M , consensus $52.97M - TipRanks
Aquestive Therapeutics: Q4 Earnings Snapshot -March 05, 2025 at 04:19 pm EST - Marketscreener.com
Aquestive Therapeutics Q4 Earnings: Anaphylm NDA Filing Process Begins as Annual Revenue Grows 14% - StockTitan
Aquestive Therapeutics (AQST) to Release Quarterly Earnings on Wednesday - Defense World
Aquestive Therapeutics (AQST) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March - The Manila Times
Aquestive Therapeutics Sets March Conference Schedule: Key Dates for Investor Access - StockTitan
Aquestive Therapeutics' SWOT analysis: PharmFilm tech could disrupt epinephrine stock By Investing.com - Investing.com South Africa
0.57%
1.50%
大文字化:
|
ボリューム (24 時間):